News Headlines Article

Panel Recommends More Testing for Obesity Drugs
New York Times

Obesity drugs should undergo clinical trials to ensure that they do not cause heart attacks, federal advisers said Thursday, a requirement that could make it harder for such drugs to gain approval.

An advisory committee to the Food and Drug Administration voted 17 to 6 to require such studies, even if there were no apparent signs that a drug increased cardiovascular risk.